-
501
Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
Published 2018-08-01“…Original study included overall 180 patients with nonalcoholic fatty liver disease that were randomized to the basic and control groups in the ratio of 2:1. …”
Get full text
Article -
502
The influence of gender and waist circumference in the association of body fat with cardiometabolic diseases
Published 2025-01-01Subjects: “…Non-alcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
503
Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy
Published 2025-01-01Subjects: Get full text
Article -
504
ЖОРСТКІСТЬ ПАРЕНХІМИ ПЕЧІНКИ ЩУРІВ ПРИ МОДЕЛЮВАННІ СТЕАТОЗУ АЛІМЕНТАРНОГО ГЕНЕЗУ ТА ЙОГО КОРЕКЦІЇ...
Published 2019-12-01Subjects: “…nonalcoholic fatty liver disease, morphological investigations, liver stiffness, shift wave elastography, steatosis, coenzyme q10, methadoxine…”
Get full text
Article -
505
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
506
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
507
-
508
Characteristics of different lipid droplet-mitochondrial contacts patterns during lipid droplet metabolism in T2DM-induced MASLD
Published 2025-01-01Subjects: “…Nonalcoholic fatty liver disease…”
Get full text
Article -
509
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
Published 2025-01-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
510
Construction of a Compound Model to Enhance the Accuracy of Hepatic Fat Fraction Estimation with Quantitative Ultrasound
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text
Article -
511
Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients
Published 2000-01-01“…The role of hepatitis C virus (HCV) RNA quantification in determining ideal interferon (IFN) treatment of noncirrhotic HCV liver disease is uncertain. The specific aim of this study was to determine whether measurement of baseline HCV RNA or changes in HCV RNA levels ( HCV RNA) early during therapy predict response to IFN in noncirrhotic HCV patients.…”
Get full text
Article -
512
-
513
-
514
Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
Published 2025-01-01Get full text
Article -
515
Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism
Published 2020-01-01Get full text
Article -
516
-
517
-
518
The Association of Depression and Anxiety Disorders With Gastrointestinal Symptoms Among Nurses
Published 2025-01-01Get full text
Article -
519
-
520